Karuna Therapeutics Operating Expenses 2011-2026 | KRTX

Annual Operating Expenses Karuna Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
495 M	300 M	181 M	71.8 M	45.4 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
495 M	45.4 M	219 M

Quarterly Operating Expenses Karuna Therapeutics

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
136 M	120 M	110 M	-	81.1 M	70.3 M	58.6 M	-	51.2 M	34.5 M	30 M	-	19.5 M	17.8 M	10.1 M	-	9.9 M	15.1 M	11.6 M	-	2.47 M	2.43 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
136 M	2.43 M	45.9 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	177 M	$ 2.11	-13.17 %	$ 217 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Axsome Therapeutics AXSM	99.1 M	$ 163.89	-	$ 8.15 B	USA
BridgeBio Pharma BBIO	304 M	$ 64.28	-3.31 %	$ 12.3 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
BioCardia BCDA	15.7 M	$ 1.37	5.81 %	$ 29 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
BioLineRx Ltd. BLRX	28.1 M	$ 2.82	-0.35 %	$ 908 M	Israel
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
BioMarin Pharmaceutical BMRN	1.47 B	$ 59.8	-3.13 %	$ 11.5 B	USA
Bristol-Myers Squibb Company BMY	12.2 B	$ 62.08	-0.46 %	$ 126 B	USA
Benitec Biopharma BNTC	9.83 M	$ 10.93	0.23 %	$ 450 M	USA
BioNTech SE BNTX	512 M	$ 109.33	-0.82 %	$ 27.2 B	Germany
Black Diamond Therapeutics BDTX	78.8 M	$ 2.38	-3.44 %	$ 131 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
BioXcel Therapeutics BTAI	107 M	$ 1.63	-2.4 %	$ 4.13 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Burford Capital Limited BUR	106 M	$ 8.65	2.49 %	$ 1.39 B	Britain
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
BeyondSpring BYSI	40.3 M	$ 1.34	-0.87 %	$ 54 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Cabaletta Bio CABA	74.7 M	$ 3.34	0.61 %	$ 3.9 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 4.88	2.74 %	$ 10.6 B	Israel
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Capricor Therapeutics CAPR	49.3 M	$ 27.28	-2.32 %	$ 731 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Catalyst Biosciences CBIO	176 M	$ 11.67	-3.47 %	$ 768 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
C4 Therapeutics CCCC	151 M	$ 3.06	13.3 %	$ 254 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Codexis CDXS	31.5 M	$ 0.99	-2.04 %	$ 72.7 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA